As of Apr 26
| -0.0005 / -0.06%|
The 1 analysts offering 12-month price forecasts for Pain Therapeutics Inc have a median target of 3.50, with a high estimate of 3.50 and a low estimate of 3.50. The median estimate represents a +340.36% increase from the last price of 0.79.
The current consensus among 2 polled investment analysts is to Buy stock in Pain Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.